Redox-Active Nanoceria Integrated with Glucose Oxidase for Glucose-Triggered Metformin Release: Promising Nanocarrier for Managing Oxidative Stress and Hyperglycemia in Diabetes Pathophysiology
ACS Applied Bio Materials · 02.11.2026 · 9 (21) · 10509-10524
DOI: 10.1021/acsabm.6c01724 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 20.10.2026. Verfasst von Bhaben Sharmah und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Diseases, CSIR-North- East Institute of Science and Technology, Jorhat785006, Assam, India. Hauptthemen laut MEDLINE: Metformin, Glucose Oxidase, Glucose, Cerium. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, Human Resource Development Group, University Grants Commission.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Development of a glucose-responsive drug delivery platform remains a promising strategy for self-regulated treatment of diabetes mellitus. In the present study, we developed a multifunctional nanocarrier system for the glucose-sensitive delivery of metformin (Met) based upon amine-functionalized nanoceria (NC-NH2) coupled with glucose oxidase (GOx) and capped with dextran. Nanoceria's inherent ability to scavenge reactive oxygen species (ROS) was made possible by its nanozyme feature, and GOx converts glucose into gluconic acid, and thereby causing drug release in a glucose-responsive manner. Drug release was controlled by the dextran shell, which served as a biocompatible gatekeeper. Under hyperglycemic conditions, the synthesized nanocarrier (NC-GOx-Met-Dex) demonstrated regulated, glucose-triggered metformin release with little release at normoglycemic levels. NC-GOx-Met-Dex showed good structural stability under physiologically simulated circumstances, selective glucose-dependent drug release kinetics in cell-free, in vitro, and ex vivo systems, and promising cellular uptake in muscle cells without causing any cytotoxicity. NC-GOx-Met-Dex enhanced glucose uptake, glucose utilization and translocation of glucose transporter protein (GLUT4) compared to the metformin-alone-treated group in palmitic acid-treated (PA, 0.75 mM) muscle cells. Further in vivo studies showed that compared to metformin alone-treated group, the nanocarrier group showed remarkable glycemic management, improvement of insulin levels, and increased metformin bioavailability in muscle tissues in animal models of diabetes mellitus. Nevertheless, NC-GOx-Met-Dex gavaging to untreated animals did not cause any abnormal behavior or adverse effects, and levels of hepato-renal biomarkers, as well as blood cell profiling, were comparable to the untreated group. In general, this research provides a viable strategy for personalized diabetes therapy through the use of a dual and multifunctional nanosystem capable of responding to hyperglycemia while preventing oxidative stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Infectious Diseases, CSIR-North- East Institute of Science and Technology, Jorhat785006, Assam, India.
- CSIR-North-East Institute of Science & Technology, Branch Itanagar, Itanagar791110, Arunachal Pradesh, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad201002, Uttar Pradesh, India.
- Institute of Advanced Study in Science and Technology , Guwahati781035, Assam, India.
- Analytical Chemistry and Sophisticated Analytical Instruments Facility Group, Chemical Science and Technology Division, CSIR-North-East Institute of Science & Technology, Jorhat785006, Assam, India.
- Chemical Science and Technology Division, CSIR-North- East Institute of Science and Technology, Jorhat785006, Assam, India.
ORCID-Profile: Subir Biswas, Arup Roy, Prasenjit Manna
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
- Human Resource Development Group
- University Grants Commission
- CSIR-North East Institute of Science and Technology
Zitieren
APA
Sharmah, B., Afzal, N. U., Barman, H., Kabir, M. E., Thapa, A., Pandit, S., Biswas, S., Roy, A., & Manna, P. (2026). Redox-Active Nanoceria Integrated with Glucose Oxidase for Glucose-Triggered Metformin Release: Promising Nanocarrier for Managing Oxidative Stress and Hyperglycemia in Diabetes Pathophysiology. ACS Applied Bio Materials, 9(21), 10509-10524. https://doi.org/10.1021/acsabm.6c01724
Vancouver
Sharmah B, Afzal NU, Barman H, Kabir ME, Thapa A, Pandit S, et al. Redox-Active Nanoceria Integrated with Glucose Oxidase for Glucose-Triggered Metformin Release: Promising Nanocarrier for Managing Oxidative Stress and Hyperglycemia in Diabetes Pathophysiology. ACS Applied Bio Materials. 2026;9(21):10509-10524. doi:10.1021/acsabm.6c01724
BibTeX
@article{Sharmah2026,
author = {Sharmah, Bhaben and Afzal, Nazim Uddin and Barman, Hiranmoy and Kabir, Mir Ekbal and Thapa, Adarsh and Pandit, Shreeram and Biswas, Subir and Roy, Arup and Manna, Prasenjit},
title = {Redox-Active Nanoceria Integrated with Glucose Oxidase for Glucose-Triggered Metformin Release: Promising Nanocarrier for Managing Oxidative Stress and Hyperglycemia in Diabetes Pathophysiology},
journal = {ACS Applied Bio Materials},
year = {2026},
volume = {9},
number = {21},
pages = {10509--10524},
doi = {10.1021/acsabm.6c01724}
}
EUVIMED